Expression of urokinase-type plasminogen activator and its receptor is up-regulated during tendon healing

Journal of Orthopaedic Research

Volumn 21, Issue 5, 2003, Pages 819-825

  Xia, Wei ^a   de Bock, Charles ^a   Murrell, George A C ^a   Wang, Yao ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Extracellular matrix; Tendon healing; Urokinase; Urokinase receptor

Indexed keywords

JOINTS (ANATOMY); PROTEINS; RNA; SYNTHESIS (CHEMICAL);

TENDON HEALING;

ORTHOPEDICS;

MESSENGER RNA; UROKINASE; UROKINASE RECEPTOR;

ACHILLES TENDON; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; GENETIC TRANSCRIPTION; IMMUNOHISTOCHEMISTRY; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; TIME; TISSUE DIFFERENTIATION; TISSUE SECTION; WESTERN BLOTTING; WOUND HEALING;

EID: 0041886968     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-0266(03)00058-5     Document Type: Article

References (28)

1. Dear AE, Medcalf RL. The urokinase-type-plasminogen-activator receptor (CD87) is a pleiotropic molecule. Eur J Biochem 1998; 252:185-93.
2. Ausubel FM, Brent R, Kingston RE. Current protocols in molecular biology. New York: Cold Spring Harbor; 1987.
3. Bajpai A, Baker JB. Urokinase binding sites on human foreskin cells. Evidence for occupancy with endogenous urokinase. Biochem Biophys Res Commun 1985;133(3):994-1000.
4. Berkenpas MB, Quigley JP. Transformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes. Proc Natl Acad Sci USA 1991;88:7768-72.
5. Best TM, Collins A, Lilly EG, Seaber AV, Goldner R. Achilles tendon healing: a correlation between functional and mechanical performance in the rat. J Orthop Res 1993;11:897-906.
6. Chapman HA, Bertozzi P, Sailor LZ, Nusrat AR. Alveolar macrophage urokinase receptors localize enzyme activity to the cell surface. Am J Physiol 1990;259(6Pt 1):L432-8.
7. Chavakis T, Willuweit AK, Lupu F, Preissner KT, Kanse SM. Release of soluble urokinase receptor from vascular cells. Thromb Haemost 2001;86:686-93.
8. Da Cunha A, Parizotto NA, De Campos Vidal B. The effect of therapeutic ultrasound on repair of the Achilles tendon of the rat. Ultrasound Med Biol 2001;27(12):1691-6.
9. Dang JJ, Wang Y, Doe WF. Sodium butyrate inhibits expression of urokinase and its receptor mRNAs at both transcription and post-transcription levels in colon cancer cells. FEBS Lett 1995; 359:147-50.
10. Dano K, Romer J, Nielsen BS, Bjorn S, Pyke C, Rygaard J, et al. Cancer invasion and tissue remodelling-cooperation of protease systems and cell types. APMIS 19991-107(1):120-7.
11. Enwemeka CS. Inflammation, cellularity, and fibrillogenesis in regenerating tendon: implications for tendon rehabilitation. Phys Ther 1989;69(10):816-25.
12. Gailit J, Clark RAF. Wound repair in the context of extracellular matrix. Curr Opin Cell Biol 1994;6:717-25.
13. Gigante A, Specchia N, Rapali S, Ventura A, de Palma L. Fibrillogenesis in tendon healing: an experimental study. Boll Soc Ital Biol Sper 1996;72:203-10.
14. Gyetko MR, Todd III RF, Wilkinson CC, Sitrin RG. The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest 1994;93(III):1380-7.
15. Gyetko MR, Sud S, Sonstein J, Polak T, Sud A, Curtis JL. Cutting edge: antigen-driven lymphocyte recruitment to the lung is diminished in the absence of urokinase-type plasminogen activator (uPA) receptor, but is independent of uPA. J Immunol 2001; 167:5539-42.
16. Hoddock RC, Spell ML, Baker III CD, Grammer JR, Parks JM, Speidel M, et al. Urokinase binding and receptor identification in cultured endothelial cells. J Biol Chem 1991;266(32):21466-73.
17. Lin JH, Wang MX, Wei AQ, Zhu W, Diwan AS, Murrell GAC. Temporal expression of nitric oxide synthase isoforms in healing Achilles tendon. J Orthop Res 2001;19:136-42.
18. Lin J, Wang MX, Wei A, Zhu W, Murrell GAC. The cell specific temporal expression of nitric oxide synthase isoforms during Achilles tendon healing. Inflamm Res 2001;50:1-8.
19. Mahdi F, Shariat-Madar Z, Todd III RF, Figueroa CD, Schmaier AH. Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells. Blood 2001; 97(III):2342-50.
20. Marsolais D, Cote CH, Frenette J. Neutrophils and macrophages accumulate sequentially following Achilles tendon injury. J Orthop Res 2001;19:1203-9.
21. McCallum FS, Maden BEH. Human18S ribosomal RNA sequence inferred from DNA sequence. Variations in 18S sequences and secondary modification patterns between vertebrates. Biochem J 1985;232:725-33.
22. More RS, Underwood MJ, Brack MJ, de Bono DP, Gershlick AH. Changes in vessel wall plasminogen activator activity and smooth muscle cell proliferation and activation after arterial injury. Cardiovasc Res 1995;29:22-6.
23. Murrell GAC, Szabo C, Hannafin JA, Jang P, Dolan MM, Deng XH, et al. Modulation of tendon healing by nitric oxide. Inflamm Res 1997;46:19-27.
24. Murrell GAC, Lilly EG, Collins A, Seaber AV, Goldner RD, Best TM. Achilles tendon injuries: a comparison of surgical repair versus no repair in a rat model. Foot Ankle 1993;14:400-6.
25. Pierleoni C, Samuelsen GB, Graem N, Ronne E, Nielsen BS, Kaufmann P. Immunohistochemical identification of the receptor for urokinase plasminogen activator associated with fibrin deposition in normal and ectopic human placenta. Placenta 1998;19:501-8.
26. Preissner KT, Kanse SM, May AE. Urokinase receptor: a molecular, organizer in cellular communication. Curr Opin Cell Biol 2000;12:621-8.
27. Romer J, Lund LR, Eriksen J, Pyke C, Kristensen P, Dano K. The receptor for urokinase-type plasminogen activator is expressed by keratinocytvs at the leading edge during re-epithelialization of mouse skin wounds. J Invest Dermatol 1994;102:519-22.
28. Wang Y. The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis. Med Res Rev 2001;21:146-70.